Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (14 ops.)
Latest filing published 22 Feb 2024 for West Pharmaceutical Services INC.
Filing timeline
BuySaleQuintin J. Lai
Insider track record
Disclosed buys
0
Disclosed sells
14
Signal history
Quintin J. Lai: trading record in brief
On August 11, 2023, Quintin J. Lai filed two sales at West Pharmaceutical Services Inc, of EUR 3,853,974 and EUR 3,110,178, the largest of a record that holds 14 sales worth EUR 14,085,996, a median of EUR 506,813. The third, EUR 1,973,658, is dated September 10, 2021. No purchase is recorded.
Quintin J. Lai, VP Corp Development & Strategy, has 29 filings published from February 21, 2019 to February 22, 2024, with 9 option exercises and 6 grants. Volume rises from 1 filing in 2019 and in 2020 to 6 in 2021, 11 in 2022 and 9 in 2023, before a last one in 2024. None falls in the last twelve months.
Publication delay is a median of 2 days, across 29 dated filings, which is quick. Trades by Lai within 30 days of colleagues at West Pharmaceutical Services Inc number 3, 3 and 3. All in the same direction. In the same order, the colleagues are Annette F. Favorite, Bernard Birkett and Charles Witherspoon.
Companies and markets linked to Quintin J. Lai
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations29 total
375 shares0Common StockSEC:0001127602-24-006392:0
7,140 shares@ US$102.513.4% of flowCommon StockSEC:0001562180-23-006338:1
3,348 shares@ US$173.222.7% of flowCommon StockSEC:0001562180-23-006338:2
1,388 shares@ US$274.291.7% of flowCommon StockSEC:0001562180-23-006338:3
453 shares@ US$369.130.8% of flowCommon StockSEC:0001562180-23-006338:4
10,725 shares@ US$394.6219.4% of flowCommon StockSEC:0001562180-23-006338:5
8,635 shares@ US$395.5415.7% of flowCommon StockSEC:0001562180-23-006338:6
1,741 shares@ US$396.123.2% of flowCommon StockSEC:0001562180-23-006338:7
8,772 shares@ US$89.6426.4% of flowCommon StockSEC:0001562180-23-006338:0
1,134 shares@ US$306.6812.0% of flowCommon StockSEC:0001562180-23-001800:0
5,576 shares@ US$83.472.1% of flowCommon StockSEC:0001562180-22-002665:1
1,271 shares@ US$367.122.1% of flowCommon StockSEC:0001562180-22-002665:2
405 shares@ US$367.940.7% of flowCommon StockSEC:0001562180-22-002665:3
1,254 shares@ US$369.862.1% of flowCommon StockSEC:0001562180-22-002665:4
446 shares@ US$370.940.8% of flowCommon StockSEC:0001562180-22-002665:5
600 shares@ US$371.891.0% of flowCommon StockSEC:0001562180-22-002665:6
900 shares@ US$372.921.5% of flowCommon StockSEC:0001562180-22-002665:7
2,940 shares@ US$374.455.1% of flowCommon StockSEC:0001562180-22-002665:8
200 shares@ US$374.920.3% of flowCommon StockSEC:0001562180-22-002665:9
2,440 shares@ US$94.277.8% of flowCommon StockSEC:0001562180-22-002665:0
3,138 shares@ US$369.1337.7% of flowCommon StockSEC:0001562180-22-001905:0
1,000 shares@ US$72.970.8% of flowCommon StockSEC:0001562180-21-005939:1
5,072 shares@ US$460.1826.6% of flowCommon StockSEC:0001562180-21-005939:2
3,100 shares@ US$460.8016.3% of flowCommon StockSEC:0001562180-21-005939:3
1,500 shares@ US$462.637.9% of flowCommon StockSEC:0001562180-21-005939:4
25 of 29 declarations
